7:24 PM
 | 
Apr 30, 2008
 |  BC Extra  |  Financial News

Cell Therapeutics raises $28.1 million

Cell Therapeutics (NASDAQ:CTIC) said it raised about $28.1 million in net proceeds under a $45 million preferred stock and notes offering to a single institutional investor. Under the deal, the company is selling $9 million of convertible preferred stock exchangeable for 11.4 million common shares and $36...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >